Immunological hurdles of ageing: Indispensable research of the human model

Ageing Research Reviews

Volumn 10, Issue 3, 2011, Pages 315-318

  Vallejo, Abbe N ^a,b,c,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Immunity; Infection; Inflammation; Older adults; Signaling; Vaccination

Indexed keywords

T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; AGING; CYTOMEGALOVIRUS INFECTION; GERIATRIC CARE; GERIATRICS; HUMAN; IMMUNE FUNCTION TEST; IMMUNE SYSTEM; IMMUNOLOGY; INNATE IMMUNITY; MEDICAL RESEARCH; REVIEW; UNITED STATES; VACCINATION;

ADAPTIVE IMMUNITY; AGED; AGED, 80 AND OVER; AGING; BIOMEDICAL RESEARCH; HEALTH SERVICES FOR THE AGED; HUMANS; IMMUNITY, INNATE; IMMUNOTHERAPY, ACTIVE;

EID: 79955972753     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arr.2011.01.005     Document Type: Review

References (47)

1. Agrawal A., Gupta S. Impact of aging on dendritic cell functions in humans. Ageing Res. Rev. 2011, 10:336-345.
2. Bate S.L., Dollard S.C., Cannon M.J. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. Clin. Infect. Dis. 2010, 50:1439-1447.
3. Bodewes R., Rimmelzwaan G.F., Osterhaus A.D. Animal models for the preclinical evaluation of candidate influenza vaccines. Expert Rev. Vaccines 2010, 9:59-72.
4. Boudet F. Vaccines for the elderly: the quest for the ideal animal model. J. Comp. Pathol. 2010, 142:S70-S73.
5. Brunner S., Herndler-Brandstetter D., Weinberger B., Grubeck-Loebenstein B. Persistent viral infections and immune aging. Ageing Res. Rev. 2011, 10:362-369.
6. Buchberger A., Bukau B., Sommer T. Protein quality control in the cytosol and the endoplasmic reticulum: brothers in arms. Mol. Cell. 2010, 40:238-252.
7. Casanova J.L., Abel L. The human model: a genetic dissection of immunity to infection in natural conditions. Nat. Rev. Immunol. 2004, 4:55-66.
8. CDC (Centers for Disease Control and Prevention), 2010. Estimates of deaths associated with seasonal influenza - United States, 1976-2007. MMWR Morb Mortal Wkly Rep 59, 1057-1062.
9. CIA (Central Intelligence Agency), 2010. The World Fact Book. Online book. ISSN 1553-8133, Central Intelligence Agency, Washington, DC. https://www.cia.gov/library/publications/the-world-factbook/index.html.
10. Colonna-Romano G., Buffa S., Bulati M., Candore G., Lio D., Pellicanò M., Vasto S., Caruso C. B cells compartment in centenarian offspring and old people. Curr. Pharm. Des. 2010, 16:604-608.
11. Crozat K., Guiton R., Guilliams M., Henri S., Baranek T., Schwartz-Cornil I., Malissen B., Dalod M. Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets. Immunol. Rev. 2010, 234:177-198.
12. D'Antona G., Nisoli E. mTOR signaling as a target of amino acid treatment of the age-related sarcopenia. Interdiscip. Top. Gerontol. 2010, 37:115-141.
13. de Brito C.A., Goldoni A.L., Sato M.N. Immune adjuvants in early life: targeting the innate immune system to overcome impaired adaptive response. Immunotherapy 2009, 1:883-895.
14. Downey J.M., Cohen M.V. Why do we still not have cardioprotective drugs?. Circ. J. 2009, 73:1171-1177.
15. Flajnik M.F., Kasahara M. Origin and evolution of the adaptive immune system: genetic events and selective pressures. Nat. Rev. Genet. 2010, 11:47-59.
16. Frasca D., Diaz A., Romero M., Landin A.M., Blomberg B.B. Age effects on B cells and humoral immunity in humans. Ageing Res. Rev. 2011, 10:330-335.
17. Grant, J., Hoorens, S., Sivadasan, S., van het Loo, M., DaVanzo, J., Hale, L., Gibson, S., Butz, W., 2004. Low Fertility and Population Ageing Causes, Consequences, and Policy Options. Monogragh MG206-EC prepared for the European Commission. RAND Europe, Leiden, Netherlands, 178 pp. http://www.rand.org/pubs/monographs/MG206.html.
18. Hayakawa Y., Huntington N.D., Nutt S.L., Smyth M.J. Functional subsets of mouse natural killer cells. Immunol. Rev. 2006, 214:47-55.
19. Japan Statistics Bureau, 2010. Statistical Handbook of Japan 2010. Ministry of Internal Affairs and Communications, Japan, chapter 17. http://www.stat.go.jp/english/data/handbook/index.htm.
20. Lang P.O., Govind S., Mitchell W.A., Siegrist C.A., Aspinall R. Vaccine effectiveness in older individuals: What has been learned from the influenza-vaccine experience. Ageing Res. Rev. 2011, 10:389-395.
21. Larbi A., Pawelec G., Wong S.C., Goldeck D., Tai J.J., Fulop T. Impact of age on T cell signaling: a general defect or specific alterations?. Ageing Res. Rev. 2011, 10:370-378.
22. McCubrey J.A., Steelman L.S., Abrams S.L., Chappell W.H., Russo S., Ove R., Milella M., Tafuri A., Lunghi P., Bonati A., Stivala F., Nicoletti F., Libra M., Martelli A.M., Montalto G., Cervello M. Emerging MEK inhibitors. Expert Opin. Emerg. Drugs 2010, 15:203-223.
23. McDade T.W. Life history theory and the immune system: steps toward a human ecological immunology. Yearbook Phys. Anthropol. 2003, 46:100-125.
24. McElhaney J.E. Influenza vaccine responses in older adults. Ageing Res. Rev. 2011, 10:379-388.
25. McKean K.A., Yourth C.P., Lazzaro B.P., Clark A.G. The evolutionary costs of immunological maintenance and deployment. BMC Evol. Biol. 2008, 8:76.
26. Mestas J., Hughes C.C. Of mice and not men: differences between mouse and human immunology. J. Immunol. 2004, 172:2731-2738.
27. NCHS, (National Center for Health Statistics), 2010. Health United States 2009: With Special Feature on Medical Technology. DHHS Publication No. 2010-1232. Centers for Disease Control and Prevention, US Department of Health and Human Services, Hyattsville, MD, 574 pp. http://cdc.gov/nchs/data/hus/hus09.pdf%23specialfeature.
28. Parham P., Abi-Rached L., Matevosyan L., Moesta A.K., Norman P.J., Older Aguilar A.M., Guethlein L.A. Primate-specific regulation of natural killer cells. J. Med. Primatol. 2010, 39:194-212.
29. Payne G., Laporte A., Deber R., Coyte P.C. Counting backward to health care's future: using time-to-death modeling to identify changes in end-of-life morbidity and the impact of aging on health care expenditures. Milbank Q 2007, 85:213-257.
30. Rice D.P., Fineman N. Economic implications of increased longevity in the United States. Annu. Rev. Public Health 2004, 25:457-473.
31. Rosenstiel P., Philipp E.E., Schreiber S., Bosch T.C. Evolution and function of innate immune receptors - insights from marine invertebrates. J. Innate Immun. 2009, 1:291-300.
32. Rosol T.J., Tannehill-Gregg S.H., LeRoy B.E., Mandl S., Contag C.H. Animal models of bone metastasis. Cancer 2003, 97:S748-S757.
33. Sansoni P., Vescovini R., Fagnoni F., Biasini C., Zanni F., Zanlari L., Telera A., Lucchini G., Passeri G., Monti D., Franceschi C., Passeri M. The immune system in extreme longevity. Exp. Gerontol. 2008, 43:61-65.
34. Shaw A.C., Panda A., Joshi S.R., Qian F., Allore H.G., Montgomery R.R. Dysregulation of human Toll-like receptor function in aging. Ageing Res. Rev. 2011, 10:346-353.
35. Stanziano D.C., Whitehurst M., Graham P., Roos B.A. A review of selected longitudinal studies on aging: past findings and future directions. J. Am. Geriatr. Soc. 2010, 58:S292-S297.
36. Shedlock D.J., Silvestri G., Weiner D.B. Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials. Nat. Rev. Immunol. 2009, 9:717-728.
37. Singh T., Newman A.B. Inflammatory markers in population studies of aging. Ageing Res. Rev. 2011, 10:319-329.
38. UN-ESA, 2005. Demograpic Revolution: The ageing of the world's population. United Nations Programme on Ageing, Department of Economic and Social Affairs, Population Division. United Nations, New York, NY. http://www.un.org/ageing/popageing_demo3.html.
39. Vallejo A.N. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol. Rev. 2005, 205:158-169.
40. Vallejo A.N., Mueller R.G., Hamel D.L., Way A., Dvergsten J.A., Griffin P., Newman A.B. Expansions of NK-like αβT cells with chronologic aging: Novel lymphocyte effectors that compensate for functional deficits of conventional NK cells and T cells. Ageing Res. Rev. 2011, 10:354-361.
41. van Elk R., Mot E., Franses P.H. Modeling healthcare expenditures: overview of the literature and evidence from a panel time-series model. Expert Rev. Pharmacoecon. Outcomes Res. 2010, 10:25-35.
42. Wadman M. Funding crisis hits US ageing research. Nature 2010, 468:148.
43. Weill J.C., Weller S., Reynaud C.A. Human marginal zone B cells. Annu. Rev. Immunol. 2009, 27:267-285.
44. Wikby A., Ferguson F., Forsey R., Thompson J., Strindhall J., Löfgren S., Nilsson B.O., Ernerudh J., Pawelec G., Johansson B. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J. Gerontol. A Biol. Sci. Med. Sci. 2005, 60:556-565.
45. Yi K.H., Chen L. Fine tuning the immune response through B7-H3 and B7-H4. Immunol. Rev. 2009, 229:145-151.
46. Zaghouani H., Hoeman C.M., Adkins B. Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol. 2009, 30:585-591.
47. Ziegler S.F. FOXP3: of mice and men. Annu. Rev. Immunol. 2006, 24:209-226.